SPINT2/HAI-2 has been found to be over-expressed in pancreatic cancer [36] and ovarian cancer [37] and has been inversely correlated with tumor progression in renal cell carcinoma [38] and breast cancer [39]. Here, SPINT2 is linked to renal cell carcinoma.